GENE ONLINE|News &
Opinion
Blog

Cancer
ASCO 2020: Global Consortiums CCC19, and TERAVOLT Improve Understanding of Cancer and COVID-19
2020-05-31
R&D
ASCO 2020: AZ’s Tagrisso Promises Disease-Free Survival in Postoperative EGFR Mutation-Positive NSCLC
2020-05-30
R&D
ASCO 2020: Maintenance Therapy with Avelumab Post-Chemo Improves Overall Survival of Bladder Cancer Patients
2020-05-29
What to Expect from the ASCO20 Virtual Program
2020-05-29
Novartis’ Kisqali Shows Promising Results in Advanced Breast Cancer Patients with Liver Metastases
2020-05-28
Colorectal Cancer: An Outlook on the Disease and Treatments
2020-05-27
Lynparza Greenlighted by FDA for HRR-Mutated, Metastatic Prostate Cancer
2020-05-27
Roche’s Tecentriq Bags Landmark FDA Approval as First-Line Monotherapy for Metastatic NSCLC
2020-05-20
CRISPR-Edited T cells Evaluated in Combating Lung Cancer
2020-05-10
AACR 2020 – Changing the Immunotherapy Paradigm
2020-05-08
R&D
AACR 2020: Modifications in Tumor Microenvironment and Host Microbiome, a Potential Therapeutic Strategy for Immunotherapy
2020-05-08
AACR 2020: What Does Cancer Therapy Mean in the Time of COVID-19?
2020-05-04
Virus-Associated Cancers and Advancements in Their Treatments
2020-05-03
AACR 2020: Targeting the KRAS Pathway – Old Protein, New Approaches
2020-04-30
AACR Conference – Major Highlights of Immunotherapy Clinical Trials
2020-04-30
1 17 18 19 20 21 22
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
EVENT
Scroll to Top